ResMed Net Income 2012-2025 | RMD
ResMed annual/quarterly net income history and growth rate from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- ResMed net income for the quarter ending December 31, 2025 was $0.393B, a 13.92% increase year-over-year.
- ResMed net income for the twelve months ending December 31, 2025 was $1.486B, a 18.99% increase year-over-year.
- ResMed annual net income for 2025 was $1.401B, a 37.2% increase from 2024.
- ResMed annual net income for 2024 was $1.021B, a 13.75% increase from 2023.
- ResMed annual net income for 2023 was $0.898B, a 15.15% increase from 2022.
|
ResMed Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $1,401 |
| 2024 | $1,021 |
| 2023 | $898 |
| 2022 | $779 |
| 2021 | $475 |
| 2020 | $622 |
| 2019 | $405 |
| 2018 | $316 |
| 2017 | $342 |
| 2016 | $352 |
| 2015 | $353 |
| 2014 | $345 |
| 2013 | $307 |
| 2012 | $255 |
| 2011 | $227 |
|
ResMed Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-12-31 | $393 |
| 2025-09-30 | $349 |
| 2025-06-30 | $380 |
| 2025-03-31 | $365 |
| 2024-12-31 | $345 |
| 2024-09-30 | $311 |
| 2024-06-30 | $292 |
| 2024-03-31 | $300 |
| 2023-12-31 | $209 |
| 2023-09-30 | $219 |
| 2023-06-30 | $230 |
| 2023-03-31 | $233 |
| 2022-12-31 | $225 |
| 2022-09-30 | $210 |
| 2022-06-30 | $195 |
| 2022-03-31 | $179 |
| 2021-12-31 | $202 |
| 2021-09-30 | $204 |
| 2021-06-30 | $195 |
| 2021-03-31 | $-78 |
| 2020-12-31 | $180 |
| 2020-09-30 | $178 |
| 2020-06-30 | $178 |
| 2020-03-31 | $163 |
| 2019-12-31 | $161 |
| 2019-09-30 | $120 |
| 2019-06-30 | $69 |
| 2019-03-31 | $105 |
| 2018-12-31 | $125 |
| 2018-09-30 | $106 |
| 2018-06-30 | $110 |
| 2018-03-31 | $110 |
| 2017-12-31 | $10 |
| 2017-09-30 | $86 |
| 2017-06-30 | $102 |
| 2017-03-31 | $88 |
| 2016-12-31 | $77 |
| 2016-09-30 | $76 |
| 2016-06-30 | $83 |
| 2016-03-31 | $91 |
| 2015-12-31 | $96 |
| 2015-09-30 | $83 |
| 2015-06-30 | $87 |
| 2015-03-31 | $91 |
| 2014-12-31 | $91 |
| 2014-09-30 | $83 |
| 2014-06-30 | $88 |
| 2014-03-31 | $90 |
| 2013-12-31 | $87 |
| 2013-09-30 | $81 |
| 2013-06-30 | $73 |
| 2013-03-31 | $85 |
| 2012-12-31 | $78 |
| 2012-09-30 | $71 |
| 2012-06-30 | $77 |
| 2012-03-31 | $65 |
| 2011-12-31 | $63 |
| 2011-09-30 | $51 |
| 2011-06-30 | $58 |
| 2011-03-31 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $38.392B | $5.146B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| Agilent Technologies (A) | United States | $36.486B | 23.12 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.032B | 0.00 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| QuidelOrtho (QDEL) | United States | $1.984B | 12.76 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |